ema semaglutide GLP-1 Drug Can Cause Rare, Potentially Blinding Side Effect, Warns EMA to Review Diabetes and

The overlapping side effect profiles and distinct mechanisms of action create risks that may be additive or synergistic

Some aim to provide even greater weight loss than current options, while others are being studied for their potential to preserve muscle mass during weight lossa key factor for maintaining metabolic health and physical performance

If in doubt, seek advice from experienced investigators or clinicians used to working with peptides.

They can have impurities or be at the wrong dosage

Protein is broken down into amino acids, which are the building blocks of protein

For some patients, obesity pharmacotherapy may be a long-term treatment rather than a time-limited intervention